Louisiana State Employees Retirement System Vir Biotechnology, Inc. Transaction History
Louisiana State Employees Retirement System
- $5.37 Billion
- Q2 2025
A detailed history of Louisiana State Employees Retirement System transactions in Vir Biotechnology, Inc. stock. As of the latest transaction made, Louisiana State Employees Retirement System holds 43,300 shares of VIR stock, worth $188,788. This represents 0.0% of its overall portfolio holdings.
Number of Shares
43,300
Previous 43,500
0.46%
Holding current value
$188,788
Previous $281,000
22.42%
% of portfolio
0.0%
Previous 0.01%
Shares
14 transactions
Others Institutions Holding VIR
# of Institutions
259Shares Held
94.8MCall Options Held
391KPut Options Held
287K-
Sb Investment Advisers (Uk) LTD London, X016.7MShares$72.7 Million0.99% of portfolio
-
Black Rock Inc. New York, NY16.4MShares$71.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.2MShares$57.7 Million0.0% of portfolio
-
State Street Corp Boston, MA5.73MShares$25 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX3.01MShares$13.1 Million0.0% of portfolio
About Vir Biotechnology, Inc.
- Ticker VIR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 132,638,000
- Market Cap $578M
- Description
- Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...